液体止血剂市场规模、份额和成长分析：按类型、应用领域、製剂类型、最终用户和地区划分－2026-2033年产业预测

2024年全球液体止血剂市场价值为7.8877亿美元，预计将从2025年的8.5976亿美元增长到2033年的17.1312亿美元。预测期（2026-2033年）的复合年增长率预计为9.0%。

全球液体止血剂市场的主要驱动力是术中高效止血管理需求的不断增长，而这又源于手术数量和复杂性的增加。注射型或塑胶化型局部止血剂，例如明胶和凝血酶基质，可以适用于传统方法难以处理的不规则伤口。它们的有效性可最大限度地减少输血需求，缩短手术时间，并降低併发症率。在微创技术发展和监管力度加大的推动下，该市场正从传统的纱布和粉末转向专用配方。随着手术操作日益复杂，对能够快速止血的液体止血剂的需求不断增长，医院也因其临床和经济效益而优先采用这些产品，这为新兴市场的创新和伙伴关係创造了条件。

全球液体止血剂市场驱动因素

外科手术数量的增加和复杂手术的日益普及，推动了临床对高效止血方案的需求不断增长。这促使医疗专业人员越来越多地选择能够适应不规则伤口形状并可快速应用的液体止血剂。外科医生日益寻求能够最大限度减少术中出血并改进微创技术的可靠工具，而医疗机构则优先考虑有助于提高手术效率和改善患者预后的产品。这一临床趋势，加上其在各个外科专科的广泛应用，正在增加医院处方笺中液体止血剂的使用频率，并推动市场内生成长。

全球液体止血剂市场面临的限制因素

由于各地监管要求复杂多样，全球液体止血剂市场面临许多挑战。这些法规可能会延迟产品上市，限制市场渗透，尤其对于含有创新生物成分或独特给药机制的液体止血剂更是如此。製造商通常需要应对漫长的审批流程，并提供大量的安全性和有效性数据。这不仅使研发工作更加复杂，也占用了原本用于商业化倡议的资源。此类挑战可能会阻碍中小企业进入市场，延缓对新产品配方的投资，并最终影响尖端止血解决方案应用于临床的速度。

全球液体止血剂市场趋势

受微创手术技术和机器人手术日益普及的推动，全球液体止血剂市场正经历显着成长。这一趋势源于临床医生对止血解决方案的需求，这些解决方案能够有效适应复杂的解剖结构，并在狭小空间内实现快速止血，从而提高手术效率。医院优先考虑有助于缩短患者住院时间和优化手术效率的产品。为此，製造商正积极推进技术创新，以实现产品与手术流程的无缝集成，例如改进包装、增强与适用器械的兼容性以及提供全面的培训支持，从而打造明显的竞争优势，满足现代外科医学不断变化的需求。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球液体止血剂市场规模：按类型和复合年增长率划分（2026-2033 年）

• 纤维蛋白类止血剂
• 胶原蛋白类止血剂
• 明胶类止血剂

全球液体止血剂市场规模：按应用和复合年增长率划分（2026-2033 年）

• 创伤病例
• 心血管外科
• 整形外科手术
• 其他的

全球液体止血剂市场规模：依剂型及复合年增长率划分（2026-2033 年）

• 液体配方
• 粉末製剂

全球液体止血剂市场规模：按最终用户和复合年增长率划分（2026-2033 年）

• 医院
• 门诊手术中心
• 其他的

全球液体止血剂市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Johnson & Johnson
• Medtronic
• B. Braun Melsungen AG
• Ethicon
• Baxter International Inc.
• Cardinal Health
• Z-Medica
• Integra LifeSciences
• MILS Biologics
• CryoLife
• CR Bard
• Sanofi
• Hemostasis, Inc.
• Source BioScience
• Teleflex Incorporated
• Stryker Corporation
• Terumo Corporation
• Abbott Laboratories
• Grifols SA
• Acelity LP Inc.

结论与建议

Global Flowable Hemostats Market size was valued at USD 788.77 Million in 2024 and is poised to grow from USD 859.76 Million in 2025 to USD 1713.12 Million by 2033, growing at a CAGR of 9.0% during the forecast period (2026-2033).

The global flowable hemostats market is primarily driven by the rising demand for efficient intraoperative bleeding control amid increasing surgical procedures and their complexity. These injectable or malleable topical agents, such as gelatin-thrombin matrices, conform to irregular wound beds where traditional methods fail. Their effectiveness minimizes the need for blood transfusions, shortens operating times, and reduces complication rates. This market has transitioned from conventional gauzes and powders to specialized formulations, propelled by the rise of minimally invasive techniques and regulatory emphasis. As surgical complexities grow, the demand for flowable hemostats that ensure rapid hemostasis intensifies, prompting hospitals to prioritize these products for their clinical and economic benefits, thus opening avenues for innovation and partnerships in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Flowable Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Flowable Hemostats Market Segments Analysis

Global flowable hemostats market is segmented by type of hemostat, application area, formulation type, end user and region. Based on type of hemostat, the market is segmented into Fibrin-based Hemostats, Collagen-based Hemostats and Gelatin-based Hemostats. Based on application area, the market is segmented into Trauma Cases, Cardiovascular Surgery, Orthopedic Surgery and Others. Based on formulation type, the market is segmented into Liquid Formulations and Powder Formulations. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Flowable Hemostats Market

The rising number of surgical procedures and more intricate interventions has led to a greater clinical demand for efficient bleeding control solutions, encouraging healthcare professionals to opt for flowable hemostats that adapt to irregular wound shapes and allow for quick application. Surgeons are increasingly seeking dependable tools to minimize intraoperative blood loss and enhance minimally invasive techniques, resulting in a trend within healthcare institutions to prioritize products that boost procedural efficiency and improve patient outcomes. This clinical inclination, coupled with broader acceptance across various surgical specialties, is driving more frequent inclusion of flowable hemostats in hospital formularies, thus promoting organic market growth.

Restraints in the Global Flowable Hemostats Market

The Global Flowable Hemostats market faces significant challenges due to complex and diverse regulatory requirements that vary by region. These regulations can hinder timely product launches and limit market penetration, especially for flowable hemostats featuring innovative biologic components or proprietary delivery mechanisms. Manufacturers are often required to navigate lengthy review processes and provide extensive data on safety and efficacy, which complicates development efforts and reallocates resources away from commercialization initiatives. Such challenges can deter smaller companies from entering the market and slow down investment in new product formulations, ultimately affecting the speed at which cutting-edge hemostatic solutions become available for clinical use.

Market Trends of the Global Flowable Hemostats Market

The Global Flowable Hemostats market is experiencing significant growth due to the escalating adoption of minimally invasive surgical techniques and robotic procedures. This trend is fueled by a clinician preference for hemostatic solutions that can effectively conform to intricate anatomies and deliver rapid hemostasis in limited spaces, thereby enhancing surgical efficacy. Hospitals are increasingly prioritizing products that contribute to shorter patient stays and optimized throughput. In response, manufacturers are innovating with improved packaging, applicator compatibility, and comprehensive training support to streamline integration into surgical workflows, creating distinct advantages that cater to the evolving demands of modern surgical practices.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Flowable Hemostats Market Size by Type of Hemostat & CAGR (2026-2033)

• Market Overview
• Fibrin-based Hemostats
• Collagen-based Hemostats
• Gelatin-based Hemostats

Global Flowable Hemostats Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Trauma Cases
• Cardiovascular Surgery
• Orthopedic Surgery
• Others

Global Flowable Hemostats Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Liquid Formulations
• Powder Formulations

Global Flowable Hemostats Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Flowable Hemostats Market Size & CAGR (2026-2033)

• North America (Type of Hemostat, Application Area, Formulation Type, End User)
  • US
  • Canada
• Europe (Type of Hemostat, Application Area, Formulation Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Hemostat, Application Area, Formulation Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Hemostat, Application Area, Formulation Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Hemostat, Application Area, Formulation Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILS Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Source BioScience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acelity L.P. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations